Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772159 · ClinicalTrials.gov registry record · Phase 1
TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
A Phase 1 study, sponsored by Mylan.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT02772159: Completed Phase 1 study, sponsored by Mylan.
NCT02772159 is a Phase 1 study that has completed, run by Mylan. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02772159, a Phase 1 study, has completed, sponsored by Mylan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of an investigational medication used to treat chronic obstructive pulmonary disease (COPD). The study drug will be tested in 6 healthy normal males. Dosing will include a single dose of study drug administered via an IV Infusion and an Oral Dose. There will be a 28 day washout period between each of the 2 dosing routes.
Interventions
- DRUG TD-4208
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
What the finished NCT02772159 record still lists
NCT02772159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which TD-4208 is the first listed.
NCT02772159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02772159 about?
NCT02772159 is a clinical study titled "TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects". The purpose of this study is to evaluate the absorption, distribution, metabolism and excretion of an investigational medication used to treat chronic obstructive pulmonary disease (COPD). The study drug will be tested in 6 healthy normal males. Dosing will include a single dose of study drug admini...
What is the current status of trial NCT02772159?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2015-06. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02772159?
The interventions under investigation include: TD-4208 (DRUG).
Who is sponsoring clinical trial NCT02772159?
This trial is sponsored by Mylan, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02772159's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia